3 Recession-Proof ETFs to Invest in Now
The U.S. gross domestic product (GDP) contracted 0.3% during the…
Sell
27
CRSP Quote, Financials, Valuation and Earnings
Last price:
$35.61
Seasonality move
:
22.33%
Day range:
$35.55 - $37.34
52-week range:
$30.04 - $67.88
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.68x
Volume:
1.7M
Avg. volume:
2.3M
1-year change:
-33.48%
Market cap:
$3.1B
Revenue:
$35M
EPS (TTM):
-$4.52
CRISPR Therapeutics AG SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
CRSP
CRISPR Therapeutics AG
|
11/06/2023 | 10-Q | 10-Q filing on 11/06/2023 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
08/07/2023 | 10-Q | 10-Q filing on 08/07/2023 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
05/08/2023 | 10-Q | 10-Q filing on 05/08/2023 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/01/2022 | 10-Q | 10-Q filing on 11/01/2022 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
08/08/2022 | 10-Q | 10-Q filing on 08/08/2022 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
05/09/2022 | 10-Q | 10-Q filing on 05/09/2022 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/03/2021 | 10-Q | 10-Q filing on 11/03/2021 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
07/29/2021 | 10-Q | 10-Q filing on 07/29/2021 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
04/27/2021 | 10-Q | 10-Q filing on 04/27/2021 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
02/16/2021 | 10-K | 10-K filing on 02/16/2021 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
10/28/2020 | 10-Q | 10-Q filing on 10/28/2020 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
07/27/2020 | 10-Q | 10-Q filing on 07/27/2020 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
04/28/2020 | 10-Q | 10-Q filing on 04/28/2020 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
02/12/2020 | 10-K | 10-K filing on 02/12/2020 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
10/28/2019 | 10-Q | 10-Q filing on 10/28/2019 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
07/29/2019 | 10-Q | 10-Q filing on 07/29/2019 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
04/29/2019 | 10-Q | 10-Q filing on 04/29/2019 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
02/25/2019 | 10-K | 10-K filing on 02/25/2019 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/07/2018 | 10-Q | 10-Q filing on 11/07/2018 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
08/07/2018 | 10-Q | 10-Q filing on 08/07/2018 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
05/08/2018 | 10-Q | 10-Q filing on 05/08/2018 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
03/08/2018 | 10-K | 10-K filing on 03/08/2018 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/08/2017 | 10-Q | 10-Q filing on 11/08/2017 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
08/10/2017 | 10-Q | 10-Q filing on 08/10/2017 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
05/11/2017 | 10-Q | 10-Q filing on 05/11/2017 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
03/10/2017 | 10-K | 10-K filing on 03/10/2017 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/22/2016 | 10-Q | 10-Q filing on 11/22/2016 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Butterfly Network the Best Small-Cap Stock?
Brought to public trading by an SPAC merger in early…
Is Spotify a Millionaire-Maker Stock?
Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…
Stock Ideas
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 10
Regencell Bioscience Holdings [RGC] is up 79.25% over the past day.
Buy
97
NGVC alert for May 10
Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.
Sell
38
ONTO alert for May 10
Onto Innovation [ONTO] is down 30.17% over the past day.
